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A B S T R A C T
Bone turnover markers (BTMs) have been considered as an auxiliary method of following the fracture
healing process and for early prediction of impaired bone healing. A better understanding of the potential
of BTMs in this application could allow for earlier interventions and improved patient care. The aim of
this study with a large animal experimental model was to assess the variation of bone formation markers
 namely the total alkaline phosphatase (ALP) and its bone-speciﬁc isoform (BALP), serum concentration
of intact osteocalcin (OC), N-terminal propeptide type III procollagen (PIIINP) and of bone resorption
markers – namely tartrate resistant acid phosphatase (TRAP) and deoxypyridinoline crosslink (DPD)
during the ﬁrst stages of a normal fracture healing process and of a segmental critical size defect (CSD),
which progresses to a non-union process. Thirty healthy female sheep (Portuguese Churra-da-Terra-
Quente breed), approximately 4-years-old, were enrolled in this study. Jugular venous blood samples
were collected pre-operatively and at 1, 2, 3, 4, 6, 8, 10 and 12 post-operative weeks. The animals of the
CSD group showed signiﬁcant lower serum levels of BALP, OC and signiﬁcant higher serum PIIINP levels at
early stages of the fracture healing process, compared with animals that progressed in a normal fracture
healing process. Serum BALP, OC and PIIINP levels could be useful as non-invasive auxiliary tools with
other complementary methods for predicting the outcome of traumatic bone fractures.
© 2017 Elsevier Ltd. All rights reserved.
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Bone turnover markers (BTMs) reﬂect the bone turnover
process and they have been largely applied in association with
dual energy [1] X-ray absorptiometry to study the pathogenesis of
post-menopausal osteoporosis, to assess the response to anti-* Corresponding author.
E-mail address: cristinamariapsousa@gmail.com (C.P. Sousa).
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injury.2017.05.025resorptive treatment and to predict fracture risk in osteoporotic
patients [1,2].
The BTMs have also been applied in the study of fracture
healing, supplying information about the organic response at the
fracture site and to the selected ﬁxation methods [3,4]. Some
studies have assessed the prognostic value of BTMs for the early
detection of an impaired fracture healing process and have veriﬁed
a different pattern of BTMs variation in patients with a normal
fracture healing process versus delayed healing or even atrophicnover markers and serum minerals variations for predicting fracture
r orthopedic research, Injury (2017), http://dx.doi.org/10.1016/j.
Table 1
Dry matter (DM) and chemical composition of feeds.
Food
Grass hay Concentrate
DM (g/kg) 88.5 90.4
Chemical composition* (g/kg DM)
Ash 5.9 8.5
NDF 73.3 31.6
CP 6.1 20.7
*CP – crude protein; NDF – neutral detergent ﬁber.
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present some difﬁculties and limitations concerning the selection
of patients that should comprise the different clinical groups, since
a great number of factors can interfere in the progression of the
fracture healing process and its classiﬁcation. Some of the
variability factors are associated with patient health conditions
(age, presence of comorbidities that interfere in bone metabolism,
tobacco consumption, etc) and to various bone fracture conditions
which may be presented (etiology, fracture classiﬁcation, severity
of the surrounding soft tissue involvement and the time that it
takes to heal) [8]. Therefore, a better understanding of the full
potential of BTMs in controlled experimental conditions will
conﬁrm its suitability as a potential indicators of fracture healing
disturbances, namely for delayed union or non-union processes,
with a view to earlier interventions to assist and/or accelerate
fracture healing. To date, no studies performed in pre-clinical large
animal models have been done which allow obtaining controlled
patterns of variation of BTMs during the expected evolution of a
normal fracture healing process versus in an experimentally
induced atrophic non-union event.
To that end, the aim of this study was to assess the variation of
bone formation markers – namely total alkaline phosphatase (ALP)
and its bone-speciﬁc isoform (BALP), serum concentration of intact
osteocalcin (OC), N-terminal propeptide procollagen type III
(PIIINP) and bone resorption markers, namely tartrate resistant
acid phosphatase (TRAP) and deoxypyridinoline crosslink (DPD),
and to evaluate their correlation with serum minerals during the
ﬁrst stages of an osteotomy healing process versus a segmental
bone critical size defect (CSD), which deﬁnitively progresses to a
non-union process, in a large animal experimental model. The
main purpose was to verify whether the pattern of variation of
these biomarkers could be correlated with speciﬁc stages of the
bone fracture healing process, in conformity with local cell
characteristics and newly formed tissues during successive stages
of bone callus formation, in both a normal fracture healing process
and during the evolution to an atrophic non-union process.
Materials and methods
Animals and surgical protocols
The animal maintenance and all experiments were reviewed
and approved by the National Animal Use and Care Committee and
undertaken according to the regulations of the European
Community Legislation on Animal Care (Authorization DGV Of.
n 0420/000/000/2009).
Thirty healthy female sheep (Portuguese Churra-da-Terra-
Quente breed) approximately 4-years-old and with an average
weight of 45 kg were acclimatised for 6 weeks before the collection
of blood samples and surgical protocol procedure. The animals
were permanently housed indoors in loose groups of 6 sheep and
kept under a constant photoperiod cycle (light: 7:00 a.m. to 7:00 p.
m.; dark: 7:00 p.m. to 7:00 a.m.), controlled temperature
(20  2 C) and humidity (50  10%). This husbandry protocol
was used in order to minimize the inﬂuence of seasonal variation
[9] and circadian rhythm on bone remodelling and serum levels of
BTMs, especially ovine OC [10,11], since an increase in the rate of
bone formation during the evening and night has previously been
reported [11,12]. The animals were fed with hay supplemented
with 0.250 kg/day of concentrate per animal, and water provided
ad libitum. The diet offered was estimated at 1.20 energy
maintenance requirements according to the National Research
Council recommendations [13]. The composition of the feeds is
shown in Table 1. The animals selected for this study were
subjected to a previous evaluation of their state of health by clinical
examination, complete blood count and general blood biochemicalPlease cite this article in press as: C.P. Sousa, et al., Evaluation of bone tur
healing versus non-union processes in adult sheep as a model fo
injury.2017.05.025analysis. The animals were examined daily and their welfare
monitored during the entire period of this study.
Six animals were used as an untreated control group for the
BTMs study. Twenty-four animals were divided in two experi-
mental groups and an osteotomy or a segmental bone CSD process
was induced. These animals were pre-medicated with acepro-
mazine maleate (5 mg EV, Calmivet; Univete, Lisboa, Portugal)
and butorphanol tartrate (0.06 mg/kg EV, Torbugesic; Fort Dodge
Veterinaria, S.A., Vall de Vianya, Girona, Spain) and anaesthesia
was induced with propofol 2% (20 mg/ml, Propofol-Lipuro; B.
Braun, Melsungen, Germany) and maintained, after tracheal
intubation, by inhalation of a mixture of 1.5% isoﬂurane (IsoFlo;
Esteve Farma, Carnaxide, Portugal) and oxygen. After sterile skin
preparation and draping of the left hindlimb, an 18-cm
longitudinal skin incision was made in its internal face to access
the medial diaphysis of the tibia. In one experimental group, a
mid-diaphysis tibial osteotomy was performed (n=12), stabilised
with an 8-hole 4.5-mm Broad Dynamic Compression Plate (Ref.
226.080; Synthes, Davos, Switzerland), contoured to the medial
aspect of the diaphysis and applied in a neutralization function. In
the other group, an 8-hole 4.5-mm Broad Lengthening Plate (Ref.
227.810; Synthes, Davos, Switzerland) was contoured to the
medial aspect of the diaphysis and provisionally attached to the
tibia shaft using two 4.5-mm unicortical screws. The remaining
holes were drilled in both cortices, also measured and tapped for
4.5-mm screws. The plate was removed and a 3-cm segmental
bone defect created (n = 12), by performing two parallel
osteotomies. In these animals, the periosteum was carefully
removed in the bone defect area. The tibia was then restored to its
original length using longitudinal traction and stabilized by
reapplying the plate, using the pre-drilled holes where the 4.5-
mm screws had been inserted. In both groups, the wound was
closed in three layers – the fascial, subcutaneous and skin layers.
Analgesia was accomplished by the administration of ﬂunixin
meglumine (1 mg/kg, IM, q24 h, Finadyne; Vetlima, Lisboa,
Portugal) for 72 h, and the animals were subjected to anti-
biotherapy with amoxicillin (15 mg/kg, IM, q48 h, Clamoxyl LA;
Laboratórios Pﬁzer, Lda., Barreiro, Portugal) during the ﬁrst week.
Wound dressings were applied around the incision, during the
ﬁrst post-operative two weeks, and frequently changed. The
animals were kept in pens during the ﬁrst two post-operative
weeks, for easier handling in the immediate post-operative
period and for restriction of movements, after which unrestricted
ambulation was allowed. In each group, the operated animals
were randomly assigned into three subgroups which were
euthanized at 3 (n = 3), 6 (n = 3) and 12 weeks (n = 6) postopera-
tively, with an IV injection of pentobarbital sodium (Eutasil;
Sanoﬁ Veterinária, Miraﬂores, Algés, Portugal) after sedation with
detomidine (Dormosedan; Pﬁzer, Auckland, New Zealand).
Collection of blood samples
In the osteotomy and segmental bone CSD groups, jugular
venous blood samples were collected pre-operatively prior tonover markers and serum minerals variations for predicting fracture
r orthopedic research, Injury (2017), http://dx.doi.org/10.1016/j.
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operatively. In the control group, the blood samples were collected
at equal intervals. Each of the samples was harvested into serum
tubes without anticoagulant (SARSTEDT – Monovette – Serum Gel
S; Nümbrecht, Germany), between 9:00 and 10:00 a.m. and before
feeding in order to reduce the inﬂuence of circadian rhythm in
serum levels of BTMs. Within 30 min of collection, the blood was
centrifuged at 3000 rpm for 10 min and the resulting serum was
harvested rapidly into 2 ml Eppendorf tubes and stored at 20 C
for serum mineral analyses and at 80 C for BTM analyses.
Serum biochemical analysis
The serum BALP activity was determined with an immuno-
capture method in a microtiter strip format using a monoclonal
anti-BALP antibody adsorbed onto strips that captured the BALP
in the sample. The enzyme activity of the captured BALP
activity was determined with para-nitrophenylphosphate (p-
NPP) substrate (METRA BALP EIA kit; QUIDEL Corporation, San
Diego, CA, USA). The serum levels of intact OC were determined
by a competitive method that uses OC coated onto strips, a
mouse anti-OC antibody, an anti-mouse IgG-ALP conjugate and
a p-NPP substrate (METRA Osteocalcin; QUIDEL Corporation,
Santa Clara, CA, USA). The DPD serum levels were assessed with
a competitive enzymatic immunoassay in a microassay strip-
well format. DPD in serum competes with ALP conjugated DPD
for binding to monoclonal anti-DPD antibody coated on the
strip. The reaction is detected with p-NPP substrate (MicroVue
tDPD; QUIDEL Corporation, Santa Clara, CA, USA). The assays
were performed in duplicate, according to the manufacturer’s
instructions, and read in a microplate reader (Multiskan EX;
MTX Lab Systems, Inc., Vienna, VA, USA), especially adapted for
enzyme-linked immunosorbent assay (ELISA). The Metra
immunoassays have cross-reactivity with ovine species. The
METRA BALP EIA test has been used in several studies in sheep
[11,14] and the cross-reactivity between the ovine and human
OC is reported as 83% [15].
The amount of PIIINP in serum was measured using an available
human radioimmunoassay kit (PIIINP Orion Diagnostica; Espoo,
Finland), with cross-reactivity with sheep [16] and read in a
gamma counter (Berthold C-12, Berthold Technologies GmbH & Co.
KG, Bad Wildbad, Germany).
Commercially available kits from Beckman Coulter (Carnaxide,
Portugal), were used for the measurement of total ALP serum
activity (ALP, Ref. 60 04) and for serum minerals concentrations,
namely calcium (Ca) (Ca-Arsenazo, Ref. 60 117), phosphorus (P)
(Inorganic Phosphorus, Ref. 61 22) and magnesium (Mg) (Magne-
sium, Ref. 61 89) using a colorimetric method, by means of
molecular absorbance spectrophotometry, and read with an
automated biochemistry analyser (Olympus AU400; Olympus
America Inc., PA, USA). TRAP serum activity (ACP, Ref. 17304;
Sentinel Diagnostics, Milano, Italy) was also measured by means of
molecular absorbance spectrophotometry16 and read in the same
chemistry analyser. All the assays were performed in duplicate, and
according to the manufacturer’s instructions.
Radiographic exams
The courses of the osteotomy healing and the non-union
process were monitored by radiographic exams. Conventional X-
ray ﬁlms (Bucky Diagnost; Philips Medical Systems, USA) were
taken just after surgery, and subsequently each month, under
sedation, in an anterior-posterior projection (70 kV, 2.5 mAs), with
a focus distance of 1-m. All radiographs were assessed for features
of bone healing such as sclerosis at fracture margins, periosteal
reaction, callus mineralisation and bridging of the fracture gap.Please cite this article in press as: C.P. Sousa, et al., Evaluation of bone tur
healing versus non-union processes in adult sheep as a model fo
injury.2017.05.025Histological analysis
Sheep tibiae specimens were ﬁxed in neutral-buffered formalin.
Specimens were cut longitudinally and a mid-section of each tibia
specimen was decalciﬁed for 24–36 h (depending on the thickness)
by immersion in a commercial solution containing EDTA di-
sodium salt (volume ratio specimen/decalciﬁer 1:100) (Osteodec;
Bio-Optica, Milano, Italy) with an acid buffer. After reconditioning,
using three steps of PBS at pH 7.4, the specimens were embedded
in parafﬁn. Sections of 5 mm thickness were stained with
Haematoxylin and Eosin (H&E) and Masson Trichrome staining
for evaluation by light microscopic examination. Masson Tri-
chrome staining allows visualizing the soft callus (ﬁbrous tissue
plus cartilage) and the hard callus tissue (newly formed bone).The
specimens were placed on a motor-driven positioning systems
(Märzhäuser Wetzlar GmbH & Co KG; Wetzlar-Steindorf, Germany)
and photographed using a digital camera (1 pixel equal to 1.63 mm
(4), DP71; Olympus, Tokyo, Japan) adapted for a microscope
(BX51; Olympus, Tokyo, Japan). The new bone of the fracture callus
and the surrounding soft tissues were the region of interest
(Photoshop CS3; Adobe Photoshop1, Adobe, San Jose, CA, USA).
Image analysis was conducted based on rule-sets considering the
colour of the new bone formation (Image ProPlus; Bethesda, CA,
USA) following control by light microscopy. “Bone area per tissue
area” (BA/TA) was determined to a square of 3 cm centred in the
defect (in the bone osteotomy). BA/TA was calculated by dividing
the area of bone area (BA) by the total tissue surface (TA) present in
the region of interest.
Statistical analysis
To determine statistical differences between experimental
groups, and between experimental groups and the control group
a Mann-Whitney U test was performed. The baseline values
obtained in each group were compared with a Wilcoxon test using
the values observed during the 12 weeks of observation. The
degree of correlation between the different biochemical param-
eters was assessed using a Spearman correlation test. All statistical
analyses were performed with SPSS (SPSS 20, SPSS Inc, Chicago, IL,
USA) statistical software. The P-values and R-values of correlations
were considered signiﬁcant at P < 0.05.
Results
The animals included in this work showed progressive recovery,
free of complications. The radiographic examination showed the
osteotomy group presenting a suitable and progressive fracture
healing process which was very consistent between animals,
although this process wasn’t fully complete at the 12th postoper-
ative week. In the CSD group an atrophic non-union process was
achieved in all the animals. However, some mineralized tissue that
proliferated from the ends of the proximal and distal bone
fragments was also observed in the fracture gap (Fig. 1).
The histologic evaluation of the bone sections of the osteotomy
group demonstrated new bone formation and the appropriate
reestablishment of the cortex contralateral to the plate. Addition-
ally, a lower cortical bone tissue formation on the sites beneath the
plate was observed, which could be related to impairment of the
vascularization due to the placement of the plate or by decreased
stimuli to bone formation caused by the reduction of load weight
bearing [17]. The plate allowed the distribution of some load over
the contralateral cortex, however directly under the bone plate the
bone tissue was subject to a lower load due to the rigidity of the
plate, thus justifying the different stimulation of bone tissue
development. In the histologic sections of the atrophic non-union
process, some indication of bone healing by the neoformation ofnover markers and serum minerals variations for predicting fracture
r orthopedic research, Injury (2017), http://dx.doi.org/10.1016/j.
Fig. 1. Radiographs of the (A) osteotomy group and (B) CSD group at 12th post-
operative week.
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fracture fragments was found; however, the defects were merely
ﬁlled with ﬁbrous and muscle tissue which collapsed from the
surrounding soft tissues.
The histomorphometric analysis demonstrated that the frac-
ture healing process in the CSD group did not present signiﬁcant
differences between the distinct time-points. Otherwise, in the
osteotomy group, the mineralized callus increased during the
course of this study, with signiﬁcant differences between the three
different time points (P < 0.05). Signiﬁcant differences were
observed between osteotomy and CSD group at the 12th week.
However, it should be mentioned that the new bone formation
presented an obvious variability between animals of the same
experimental group (Table 2).
Excluding DPD, all BTMs revealed broad inter-individual
variations, during the entire 12-week period of observation. In
the control group, signiﬁcant time-dependent changes were seen
concerning BALP serum activity during the observed 12-week
period (P < 0.05). In this group, for the others parameters, time-
dependent changes were not veriﬁed during the study period.
In the osteotomy group, the ALP and BALP serum activities and
OC serum levels observed during the fracture healing process were
signiﬁcantly higher compared to their relevant preoperative
normal values (P < 0.01, P < 0.05, P < 0.001, respectively). The
ALP serum activity was higher in the control group than in the
osteotomy and CSD group. The osteotomy group also showed an
increase in their ALP serum activity from the 3rd postoperative
week (Fig. 2). No signiﬁcant differences could be observed for the
serological course of ALP between the osteotomy and CSD group.Table 2
Histomorphometrical analysis.
Osteotomy CSD
BA/TA
(%)
3 week 6 week 12 week 3 week 6 week 12 week
Median 2.60 38.00 41.79yy 1.84 2.10 8.40
Minimum 1.30 5.60 11.85 0.80 1.60 2.50
Maximum
CV
4.2
64.8
57.00
77.5
70.03
53.7
2.60
76.5
9.90
78.0
18.34
70.0
yySigniﬁcant compared with CSD group for the same post-operative time (p < 0.01).
BA: bone area: TA: tissue area.
Please cite this article in press as: C.P. Sousa, et al., Evaluation of bone tur
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BALP serum activity until the 3rd postoperative week. The BALP
serum activity subsequently returned to the preoperative level
around the 8th postoperative week. The animals of the CSD group
also showed an increase of their BALP serum activity until the 4th
postoperative week followed by a decrease around the 6th
postoperative week (Fig. 2). It was also observed that the animals
of the osteotomy group showed higher values of their BALP serum
activity than the animals of the CSD group, during the entire post-
operative period, with signiﬁcant values until the 6th week.
The osteotomy group showed increased OC levels until the 2nd
week, declining in the 3rdweek, followed by an increase around the
4th postoperative week, with the values being higher than the
preoperative levels during the entire study period. In the CSD
group, the course of OC showed a signiﬁcant increase just around
the 8th week (Fig. 2). The osteotomy group showed also higher
values than the animals of CSD group, during the postoperative
period, with signiﬁcant levels until the 4th week.
The osteotomy group showed a slight increase in their TRAP
serum activity between the 4th and the 6th postoperative weeks.
However, no signiﬁcant differences were observed in the remain-
ing postoperative time-points compared with those obtained
preoperatively. A similar pattern of variation was observed in the
CSD group (Fig. 2). Signiﬁcant differences were observed between
groups at the 3th postoperative week.
The animals in the osteotomy group did not present differences
for the serological course of PIIINP levels during the postoperative
period. Otherwise, PIIINP serum levels observed during the
postoperative period in the CSD group were signiﬁcantly higher
than their preoperative normal values (P < 0.001). This group
showed signiﬁcant time-dependent changes of PIIINP serum levels
during the entire postoperative period (Fig. 2). It was also observed
that the serum levels of PIIINP were signiﬁcantly higher in the CSD
group than in the osteotomy group throughout the postoperative
period.
In the osteotomy group, an increase of DPD serum levels was
observed around the 4th postoperative week while in the CSD
group a signiﬁcant decrease from the preoperative values was
observed around the 6th postoperative week (Fig. 2). Signiﬁcant
differences between groups were observed at the 4th postoperative
week.
The serological course of serum minerals in the studied groups
was not affected by the fracture healing process, and signiﬁcant
differences were not observed during the postoperative period or
between the different groups (Fig. 2).
The degree of correlations between the biochemical parameters
in study was signiﬁcant between ALP and Ca (R = 0.37, P < 0.05),
ALP and P (R = 0.41, P < 0.05), ALP and OC (R = 0.44, P < 0.05), BALP
and OC (R = 0.28, P < 0.05), BALP and DPD (R = 0.27, P < 0.05), OC
and DPD (R = 0.39, P < 0.05), OC and Ca (R = 0.54, P < 0.01) and Ca
and P (R = 0.352, P < 0.05), in the osteotomy group (Table 3). In the
CSD group signiﬁcant correlation was observed between ALP and
Ca (R = 0.38, P < 0.05), ALP and P (R = 0.33, P < 0.05), ALP and DPD
(R = 0.397, P < 0.05), BALP and OC (R = 0.25, P < 0.05), BALP and
PIIINP (R = 0.24, P < 0.05), OC and PIIINP (R = 0.21, P < 0.05), PIIINP
and TRAP (R = 0.29, P < 0.05) and Ca and P (R = 0.401, P < 0.05)
(Table 4).
Discussion
The aim of this study was to evaluate whether BTMs are a
suitable prognostic markers to assess the fracture healing process.
A large animal model was used for this purpose. In order to exclude
the inﬂuence of variability sources that have a clear inﬂuence on
serum levels of BTMs an osteotomy or a CSD was induced in sheepnover markers and serum minerals variations for predicting fracture
r orthopedic research, Injury (2017), http://dx.doi.org/10.1016/j.
Fig. 2. Serological course of bone turnover markers and serum minerals during the post-operative period (Mean  S.D. green line: osteotomy group; blue line: CSD group;
brown line: control group; * signiﬁcant differences compared to their preoperative (baseline) values; signiﬁcant differences compared to previous time-point; ySigniﬁcant
compared with control group for the same post-operative time (yp < 0.05, yy p < 0.01); zSigniﬁcant compared with CSD for the same post-operative time (zp < 0.05, zzp < 0.01)).
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Table 3
Correlations between BTM and serum minerals in the osteotomy group.
ALP (U/l) BALP (U/l) OC (mg/l) PIIINP (mg/l) DPD (mg/l) TRAP (U/l) Ca (mmol/l) P (mmol/l)
ALP (U/l) R = 1.00
BALP (U/l) R = 0.20 R = 1.00
OC (mg/l) *R = 0.44
P = 0.02
*R = 0.28
P = 0.006
R = 1.00
PIIINP (mg/l) R = 0.03 R = -0.0239 R = 0.05 R = 1.00
DPD (mg/l) R = 0.016 *R = 0.27
P = 0.006
*R = 0.39
P = 0.0001
R = 0.06 R = 1.00
TRAP (U/l) R = 0.030 R = 0.161 R = 0.10 R = -0.14 R = -0.07 R = 1.00
Ca (mmol/l) *R = 0.37
P = 0.001
R = 0.14 *R = 0.54
P = 0.001
R = 0.16 R = 0.04 R = 0.14 R = 1.00
P (mmol/l) *R = 0.41
P = 0.004
R = 0.14 R = 0,21 R = 0.034 R = 0.10 R = 0.37 *R = 0.35
P = 0.004
R = 1.00
*Signiﬁcant values
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healing process or an atrophic non-union process, respectively.
It has been estimated that 5–10% of all patients with long bone
fractures will develop impaired fracture healing processes, namely
delayed union and non-union processes [17]. Therefore, there is a
real need for clinicians to have tools to better assess the fracture
healing process, which can improve patients care. Several studies
have demonstrated that serum and urinary BTMs are capable of
reﬂecting fracture healing, with their levels dependent on the
location, type and size of the fracture [3,4]. Although different
serum BTMs levels are associated with different stages of the
healing process, their clinical effectiveness for early prediction of
impaired fracture healing processes is not clear, with different
clinical trials presenting heterogeneous results [18].
This study demonstrated similar and simultaneous variations
for BALP and OC serum values throughout the entire post-operative
period in both experimental groups under study. When compared
with the untreated control group it was evident that these
parameters are inﬂuenced by the fracture healing process. BALP is
a membrane bound enzyme which is synthesized and expressed at
relatively high levels by osteoblasts during the production of
osteoid and several studies indicate its involvement in the
mineralization of the bone extracellular matrix (ECM)[19,20].
The OC is a non-collagenous bone protein, also synthesized by
osteoblasts and present in the ECM, representing 15–20% of the
non-collagenous bone ECM [21]. Therefore, in the present study,
the increase in the osteotomy group of BALP serum activity and OC
serum levels during the post-operative period may be associated
with an active synthesis and maturation stage of bone ECM by
osteoblasts. The high signiﬁcance of the correlation veriﬁed
between serum BALP and OC, OC and Ca and between OC and P
supports a probable association between these parameters, theTable 4
Correlations between BTM and serum minerals in the CSD group.
ALP (U/l) BALP (U/l) OC (mg/l) PIIINP (mg
ALP (U/l) R = 1.00
BALP (U/l) R = 0.15 R = 1.00
OC (mg/l) R = 0.05 *R = 0.25
P = 0.02
R = 1.00
PIIINP (mg/l) R = 0.11 *R = 0.23
P = 0.019
*R = 0.2
P = 0.04
R = 1.00
DPD (mg/l) *R = 0.40
P = 0.005
R = 0.01 R = -0.15 R = 0.12 
TRAP (U/l) R = 0.04 R = 0.18 R = 0.28 *R = 0.29
P = 0.04
Ca (mmol/l) *R = 0.38
P = 0.008
R = -0.005 R = 0.08 R = 0.15 
P (mmol/l) *R = 0.33
P = 0.02
R = 0.20 R = 0,096 R = 0.16 
*Signiﬁcant values.
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tion process of the osteoid. The lower serum OC and BALP levels in
the CSD group could reﬂect a reduction in bone formation
associated with poor osteoblastic activity. Nevertheless, signiﬁcant
differences concerning new bone formation were not observed, at
the 3rd and 6th post-operative weeks, when the histomorpho-
metrical results were assessed, which could be related with the
small number of animals incorporated in this analysis and with the
signiﬁcant variability that was observed (Table 2).
Concerning BALP activity, Emami et al. [22] also found lower
levels in patients with delayed union at an early time-point during
the fracture healing process, namely at the 4th post-traumatic
week, than in patients with a normal bone union process. However,
these results are not in accord with results obtained by Herrman
et al. [23], Marcelli et al. [6] and Moghaddam et al. [5], where
serum BALP activity was not capable of predicting bone fracture
healing outcome, because signiﬁcant differences were not
observed in serum BALP activity during the healing process,
despite different outcomes. In studies by Oni et al. [24] and
Herrmann et al. [23] in patients with diaphyseal fractures of long
bone stabilized with conservative and osteosynthesis techniques,
the sequential measurement of serum OC concentration was a
valid aid in the early detection of patients at risk of developing an
impaired union process. However, Oni et al. [24] reported lower OC
concentration throughout the entire study period in the group of
patients that progressed to impaired bone union than the group
with a normal bone union. In turn, Herrmann et al. [23] observed a
delay in the rise of the OC concentration in the group of patients
that presented an impaired healing process.
The serum levels of ALP are the sum of four isoenzymes:
intestinal, placental, liver and bone. The BALP and the liver
isoforms represent the most relevant fraction of the total ALP/l) DPD (mg/l) TRAP (U/l) Ca (mmol/l) P (mmol/l)
R = 1.000
*R = 0.31
P = 0.03
R = 1.00
R = 0.08 R = 0.22 R = 1.00
R = 0.42 R = 0.09 *R = 0.40
P = 0.005
R =
1.000
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enzyme [19]. In the present study, were found differences in the
serum levels of ALP between control, osteotomy and CSD groups,
with the control group having higher values than the other two
experimental groups. However, considering the variation pattern
observed for BALP, it would be expected that the osteotomy group
animals would present higher values. Despite the controlled
environment of the experiment, the presence of variables, which
were not considered and which could inﬂuence the remaining
isoforms cannot be excluded.
In contrast to a previous experimental study conducted in
sheep by Klein et al. [25] and in accordance with a clinical trial
conducted by Kurdy et al. [26], the serum PIIINP levels appear to be
suitable for the early detection of an impaired healing process.
Kurdy et al. found signiﬁcantly higher PIIINP values at the 10th
postoperative week in patients with delayed union than in patients
who presented a suitable fracture healing process [26]. In this work
the higher PIIINP levels observed in the CSD group are supported
by histological ﬁndings from another study which observed high
amounts of collagen type III expressed by mature osteoblasts on
woven bone surfaces in abnormal healing fractures and, in
contrast, normal fracture healing processes presented collagen
type III expression only at early stages, and it is very rarely seen in
osteoblasts [27]. Klein et al. [25] performed a standardized
osteotomy on the tibia, which was stabilized with either an
external ﬁxator or with a nail locked with medio-lateral inserted
bolts. During the healing process, interfragmentary movements
and axial torsion was signiﬁcantly higher in the group stabilized
with the tibial nail than in the group with external ﬁxators.
Therefore, since the degree of stability at the bone ends was
different, it should be expected that the groups presented distinct
healing evolutions, with the ﬁrst group showing a delayed union
compared to the second group. Despite differences on the level of
fracture callus consolidation, the serum PIIINP were not sensitive
enough to detect changes in the healing process and no signiﬁcant
differences were observed [25]. In regard to the limitations of
experimental studies, and in comparison to clinical situations, this
model could not completely demonstrate the pathophysiological
mechanisms underlying an impaired healing process.
The results of the present work are able to support the
previously described ﬁndings of lower levels of bone resorption
markers at an early time-point in the impaired healing group
compared with the normal healing group [5]. In other studies,
serum TRAP levels have proved to be a promising marker of bone
resorption, being sensitive, speciﬁc and capable of detecting early
bone metastases from breast cancer [28], predicting the occur-
rence of pathological fractures in elderly women [29] and
diagnosing aseptic loosening of hip arthroplasty [30]. Concerning
serum DPD, Southwood et al. [31] veriﬁed that the measurement of
serum DPD levels can be effective for the assessment of the fracture
healing process and early diagnosis of osteomyelitis. However, and
in contrast with the present study, the authors veriﬁed higher
serum levels of DPD in the non-union group at the 4th
postoperative week than in the non-infected control group. These
distinct results could be related with the different models designed
to reproduce a non-union process, namely a CSD with periosteal
cauterization or the inoculation of colony-forming units of
Staphylococcus aureus in a fracture gap.
The high inter-individual variation observed in the control
group for all the assessed parameters, even under standardized
conditions, could decrease overall suitability if this variation is not
taken into account. Similar to previous reports in other studies, the
major limitation for the application of BTMs relates to their
variability [32].
In conclusion, serum BALP, OC, TRAP, DPD and PIIINP levels
could be useful as non-invasive auxiliary tools with otherPlease cite this article in press as: C.P. Sousa, et al., Evaluation of bone tur
healing versus non-union processes in adult sheep as a model fo
injury.2017.05.025complementary methods for predicting the outcome of traumatic
bone fractures. Impaired healing processes are associated with
abnormally high amounts of collagen type-III expressed by
osteoblasts on woven bone surfaces at an early post-operative
time-point and are correlated with higher serum PIIINP levels
observed in these patients. Consequently, such ﬁndings suggest
that serum PIIINP levels can be a promising marker to detect
fracture healing disturbances.
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